Longbow Finance’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,686
| Closed | -$9.06M | – | 99 |
|
|
2025
Q1 | $9.06M | Sell |
18,686
-4,013
| -18% | -$1.95M | 1.09% | 27 |
|
|
2024
Q4 | $9.14M | Buy |
22,699
+16,028
| +240% | +$6.45M | 1% | 27 |
|
|
2024
Q3 | $3.1M | Sell |
6,671
-7,954
| -54% | -$3.7M | 0.33% | 66 |
|
|
2024
Q2 | $6.86M | Sell |
14,625
-878
| -6% | -$412K | 0.71% | 34 |
|
|
2024
Q1 | $6.48M | Sell |
15,503
-40,991
| -73% | -$17.1M | 0.66% | 41 |
|
|
2023
Q4 | $23M | Buy |
56,494
+2,605
| +5% | +$1.06M | 2.33% | 8 |
|
|
2023
Q3 | $18.7M | Buy |
53,889
+12,433
| +30% | +$4.32M | 2.25% | 11 |
|
|
2023
Q2 | $14.6M | Sell |
41,456
-25
| -0.1% | -$8.8K | 1.7% | 19 |
|
|
2023
Q1 | $13.1M | Buy |
41,481
+418
| +1% | +$132K | 1.65% | 21 |
|
|
2022
Q4 | $11.9M | Buy |
+41,063
| New | +$11.9M | 1.6% | 26 |
|